Phone: 734-615-9635|Email: vbidcenter@umich.edu
FacebookXYouTubeLinkedIn

Interns

About V-BID Interns

This author has not yet filled in any details.
So far V-BID Interns has created 328 blog entries.

Sunday, June 12, 2016: China’s Health Economics and Policy for “Moon Shot” Precision Medicine Roundtable Discussion

On Sunday, June 12th, Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), will speak at the Chinese Economist Society's Roundtable Discussion on precision medicine.  The roundtable discussion is part of a larger event, titled "The Fourth Shenzhen International Low Carbon City Forum," and will take place in Shenzhen, Guangdong Province, China.  Dr. Fendrick will also participate in an additional forum event held on Monday, June 13th.   The roundtable event will bring together health economists and policy stakeholders to discuss the opportunities and challenges of using genomic science to improve the quality and efficiency of health care and public health services delivery in China and internationally.  Dr. Fendrick will discuss V-BID in the context of the Chinese health system and precision medicine. Dr. Fendrick's presentation and the event agenda can be found below.     Dr. Fendrick addressing the Chinese Economic     [...]

V-BID Interns2020-01-10T20:36:35+05:00May 18th, 2016|Uncategorized|
Read More

Monday, May 23, 2016: Military Health System Value-Based Care Summit

On Monday, May 23rd, Dr. A. Mark Fendrick, V-BID Center Director, spoke about value-based insurance design (V-BID) at the Military Health System (MHS) Value-Based Care Summit at the Defense Health Headquarters.  The event was hosted by the Defense Health Agency (DHA) and took place just outside Washington, D.C. Dr. Fendrick served as the keynote speaker for the summit, which brought together senior leaders in the Armed Services and key personnel from the DHA and TRICARE.  Dr. Fendrick's presentation, "Enhancing Value in the Military Health System:  Using 'Clinical Nuance' to Align Provider and Consumer Incentives," highlighted the long-term strategy, rationale, and utility for implementing V-BID in the MHS. Dr. Fendrick's presentation, as well as the detailed MHS summit brochure and agenda are available below. Presentation  Summit Brochure  Summit Agenda  In February of this year, Dr. Fendrick testified before the US Senate Committee on [...]

V-BID Interns2019-10-30T18:16:52+05:00May 9th, 2016|Events|
Read More

V-BID Whiteboard Video: Reward the Good Soldier

Access to prescription drugs is a hot-button health care issue. The V-BID center proposes an innovative and dynamic benefit design - Reward the Good Soldier - that recognizes that individualized therapies are often needed to achieve desired health outcomes.

V-BID Interns2020-01-17T19:42:26+05:00April 27th, 2016|Uncategorized|
Read More

Narrow Networks and Value-Based Insurance Design

Narrow Networks and Value-Based Insurance DesignExecutive SummaryNarrow networks aim to improve patient outcomes and increase quality of care by establishing a pool of providers to supply consumers with high-value, evidence-based care.  This concept incorporates Value-Based Insurance Design (V-BID) principles, aligning patients’ out-of-pocket costs with the clinical value of services.  However, narrow networks are often a source of confusion for consumers who may struggle to understand provider groups and performance metrics.  Additionally, these value-based networks face the obstacle of ensuring an adequate network of providers for their patient population.  Despite these challenges, narrow networks remain a promising alternative to traditional health coverage plans that may help contain costs, while improving patient outcomes.BackgroundNarrow networks are a type of benefit design made popular by managed care organizations in the 1980s and 90s, and are gaining traction once again, in part due to the Affordable Care Act.  Aimed at cost containment, narrow networks [...]

V-BID Interns2020-09-18T21:14:29+05:00April 20th, 2016|Briefs|
Read More

VBID: How Clinically Nuanced Care Became a Game Changer

This interactive timeline highlights the history of Value-Based Insurance Design (V-BID) from the conception of clinically nuanced cost-sharing to the implementation of V-BID principles into private and public health plans across the country.

V-BID Interns2020-01-07T20:42:04+05:00April 8th, 2016|Interactive Timeline|
Read More

March 2016 News Update

This month's V-BID news update discusses recent support in the US House of Representatives, a new V-BID proposal from CMS, and a myriad of academic and news publications.

V-BID Interns2016-04-01T02:03:31+05:00April 1st, 2016|Center Updates|
Read More

The History of V-BID in the Medicare Program

This interactive timeline explores the history of Value-Based Insurance Design (V-BID) in Medicare and Medicare Advantage. It all began in 2005 with the founding of the V-BID Center. Since then, legislation has been written, public support has been strong, and V-BID has been infused into Medicare and Medicare Advantage policy.

V-BID Interns2019-12-13T22:51:11+05:00March 28th, 2016|Interactive Timeline|
Read More

February 2016 News Update

The February 2016 V-BID news update highlights V-BID in action in defense health care reform, Michigan Medicaid, and Medicare Advantage. The news update also features recent research and popular press publications, and three newly developed V-BID infographics.

V-BID Interns2019-10-30T18:16:53+05:00February 29th, 2016|Center Updates|
Read More

Senate Committee on Armed Services Testimony

On Tuesday, February 23rd, Dr. A. Mark Fendrick, Director of The Center for Value-Based Insurance Design, testified before the United States Senate Committee on Armed Services Subcommittee on Personnel. Dr. Fendrick discussed how the principles of value-based insurance design (V-BID) and clinical nuance can contribute positively to defense health care reform.

V-BID Interns2019-10-30T18:16:53+05:00February 23rd, 2016|Videos|
Read More

February 23, 2016: US Senate Committee on Armed Services

On Tuesday, February 23rd, Dr. A. Mark Fendrick, V-BID Center Director, testified before the United States Senate Committee on Armed Services Subcommittee on Personnel.  Dr. Fendrick discussed how the principles of value-based insurance design (V-BID) and clinical nuance can contribute positively to defense health care reform.https://youtu.be/zprEwpVgXCo  Additional testimony materials available below:                                              

V-BID Interns2020-01-13T14:43:50+05:00February 23rd, 2016|Events, Press Releases, Testimonies|
Read More

February 9, 2016: MI Senate Appropriations Subcommittee on HHS Hearing

On Tuesday, February 9th, Dr. A. Mark Fendrick, V-BID Center Director, testified before the Michigan Senate Appropriations Subcommittee on Health and Human Services in Lansing, Michigan. Dr. Fendrick discussed opportunities to improve the health of Michigan residents through the utilization of value-based services and performance metrics, as well as how clinically nuanced cost-sharing has been an effective way to improve value and creates an opportunity for broad innovation in the Medicaid space.  Value-based insurance design (V-BID) principles are included in the Healthy Michigan Plan for Medicaid expansion, as outlined in the V-BID Center's Michigan Medicaid brief. The Hearing announcement can be accessed here. More Hearing materials are available below:   Presentation  Slides      Clinical Nuance Infographic   

V-BID Interns2021-07-29T23:24:53+05:00February 9th, 2016|Resources, Testimonies|
Read More

Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design

Supporting Consumer Access to Specialty Medications through Value-Based Insurance Design Originally Produced:  June 2014   Updated:  February 2017 Introduction Specialty pharmaceuticals are medications that consist of complex molecules, are often complicated to deliver, and/or carry high costs.  These medications are frequently used in the treatment of rheumatoid arthritis (RA), HIV, multiple sclerosis (MS), cancer and a variety of other serious health conditions.  For many patients, specialty medications represent the most appropriate clinical recommendation.  However, the benefit delivered by any given medication may vary markedly depending on the particular circumstances around its use.  Today, approximately a quarter of total pharmaceutical spend-ing in the commercial market is devoted to specialty medications.  If current trends in utilization hold, it is estimated that spending on specialty medications will comprise half of all pharmaceutical expenditures by 2018.1 To constrain the rapid rate of increased spending, many payers have established high consumer cost-sharing requirements [...]

V-BID Interns2020-01-03T17:50:52+05:00June 1st, 2014|Briefs|
Read More

734-615-9635 | 2800 Plymouth Road, Building 16, Floor 4, Ann Arbor, MI 48109-2800

Go to Top